In another study, Tian et al.[183] recognized the clonal enrichment of NB-CSCs (CD133+) with chemodrug (etoposide) identified the potential of XAV939 a small molecule tankyrase (TNKS) inhibitor in alleviating the stemness physiognomy and migration of NB-CSCs. Here, PROM1 is linked to neuroblastoma.